当前位置: 首页 >> 检索结果
共有 4350 条符合本次的查询结果, 用时 4.1240034 秒

3521. Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial.

作者: Marcela Ag Salazar-Parra.;Roberto U Cruz-Neri.;Xóchitl Ar Trujillo-Trujillo.;Juan J Dominguez-Mora.;Héctor I Cruz-Neri.;Jazmín M Guzmán-Díaz.;Mario J Guzmán-Ruvalcaba.;Jesús O Vega-Gastelum.;Kriscia V Ascencio-Díaz.;Maria F Zarate-Casas.;Fanny Y González-Ponce.;Francisco J Barbosa-Camacho.;Clotilde Fuentes-Orozco.;Gabino Cervantes-Guevara.;Enrique Cervantes-Pérez.;Guillermo Alonso Cervantes-Cardona.;Ana Olivia Cortés-Flores.;Alejandro González-Ojeda.
来源: BMC Gastroenterol. 2023年23卷1期229页
Probiotics are effective for treating acute infectious diarrhoea caused by bacteria, but there are inconsistent results for the effectiveness of probiotics for diarrhoea caused by viruses. In this article we want to determine whether Sb supplementation has an effect on acute inflammatory viral diarrhoea diagnosed with the multiplex panel PCR test. The aim of this study was to evaluate the efficacy of Saccharomyces boulardii (Sb) as a treatment in patients diagnosed with viral acute diarrhoea.

3522. Associations and gastrointestinal symptoms in women with endometriosis in comparison to women with irritable bowel syndrome: a study based on a population cohort.

作者: Sofie Stark Junkka.;Bodil Ohlsson.
来源: BMC Gastroenterol. 2023年23卷1期228页
Endometriosis and irritable bowel syndrome (IBS) have similar symptoms, pathogenesis, and risk factors. These diagnoses often coexist and are frequently misdiagnosed leading to diagnostic delays. This study of a population-based cohort aimed to investigate associations relating to endometriosis and IBS and to compare gastrointestinal symptoms between endometriosis and IBS.

3523. Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort study.

作者: Ghazal Daftari.;Asal Neshatbini Tehrani.;Fereshteh Pashayee-Khamene.;Sara Karimi.;Saleheh Ahmadzadeh.;Azita Hekmatdoost.;Amin Salehpour.;Mahdi Saber-Firoozi.;Behzad Hatami.;Zahra Yari.
来源: BMC Gastroenterol. 2023年23卷1期227页
Liver cirrhosis is a worldwide burden and is associated with poor clinical outcomes, including increased mortality. The beneficial effects of dietary modifications in reducing morbidity and mortality are inevitable.

3524. Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study.

作者: Kai Li.;Yusheng Lin.;Yu Zhou.;Xiao Xiong.;Lu Wang.;Junkuo Li.;Fuyou Zhou.;Yi Guo.;Shaobin Chen.;Yuping Chen.;Hui Tang.;Xiaofu Qiu.;Songwang Cai.;Dianzheng Zhang.;Edwin Bremer.;Sai-Ching Jim Yeung.;Hao Zhang.
来源: Gastroenterology. 2023年165卷4期932-945.e9页
Early detection of esophageal squamous cell carcinoma (ESCC) will facilitate curative treatment. We aimed to establish a microRNA (miRNA) signature derived from salivary extracellular vesicles and particles (EVPs) for early ESCC detection and prognostication.

3525. Psychological Processes, Not Physiological Parameters, Are Most Important Contributors to Symptom Severity in Patients With Refractory Heartburn/Regurgitation Symptoms.

作者: Livia Guadagnoli.;Annelies Geeraerts.;Hannelore Geysen.;Ans Pauwels.;Tim Vanuytsel.;Jan Tack.;Lukas Van Oudenhove.
来源: Gastroenterology. 2023年165卷4期848-860页
Physiological and psychological factors have been found to influence esophageal symptom reporting. We aimed to evaluate which of these factors are associated with 3 reflux symptom severity outcomes (ie, Total Reflux, Heartburn, and Sleep Disturbance) through a traditional statistical and a complementary machine-learning approach.

3526. Construction and external validation of a nomogram model for predicting the risk of esophageal stricture after endoscopic submucosal dissection: a multicenter case-control study.

作者: Zhao Mu.;Xiao Tang.;Jingting Wang.;Yulin Chen.;Kui Cui.;Xingyu Rao.;Juan Li.;Guodong Yang.
来源: BMC Gastroenterol. 2023年23卷1期226页
Esophageal stricture is a common complication after endoscopic submucosal dissection (ESD) for superficial esophageal cancer and precancerous lesions, we intend to investigate the independent risk factors of esophageal stricture after ESD by adding the data of included living habits, established a nomogram model to predict the risk of esophageal stricture, and verified it by external data. The clinical data and living habits of patients with early esophageal cancer and precancerous lesions who underwent ESD in the Affiliated Hospital of North Sichuan Medical College and Langzhong People's Hospital from March 2017 to August 2021 were retrospectively collected. The data collected from the two hospitals were used as the development group (n = 256) and the validation group (n = 105), respectively. Univariate and multivariate logistic regression analyses were used to determine independent risk factors for esophageal stricture after ESD and establish a nomogram model for the development group. The prediction performance of the nomogram model is internally and externally verified by calculating C-Index and plotting the receiver operating characteristic curve (ROC) and calibration curve, respectively. The results showed that Age, drinking water temperature, neutrophil-lymphocyte ratio, the extent of esophageal mucosal defect, longitudinal diameter of resected mucosa, and depth of tissue invasion (P < 0.05) were independent risk factors for esophageal stricture after ESD. The C-Index of the development group and validation group was 0.925 and 0.861, respectively. The ROC curve and area under the curve (AUC) of the two groups suggested that the discrimination and prediction performance of the model were good. The two groups of calibration curves are consistent and almost overlap with the ideal calibration curve, indicating that the predicted results of this model are in good agreement with the actual observed results. In conclusion, this nomogram model has a high accuracy for predicting the risk of esophageal stricture after ESD, providing a theoretical basis for reducing or avoiding esophageal stricture and guiding clinical practice.

3527. A Rare Cause of Abdominal Pain.

作者: Minh Do.;Sridevi K Pokala.;Michael C Yang.;Augustin Attwell.
来源: Gastroenterology. 2024年166卷1期e10-e12页

3528. The Enteric Nervous System: A Link Between Stress and Colitis.

作者: David Reed.
来源: Gastroenterology. 2023年165卷5期1304页

3529. Hemostatic Powder Offers Patients Respite From Malignant Gastrointestinal Bleeding.

作者: Andrew Y Wang.
来源: Gastroenterology. 2023年165卷3期536-537页

3530. Study on the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients.

作者: Fei Chen.;Hongbo Li.;Huanming Zhang.
来源: Minerva Gastroenterol (Torino). 2024年70卷1期135-137页

3531. Curcumin inhibits liver cancer by regulating Bcl-9/β-catenin pathway.

作者: Gang Wang.;Meng Lu.;Hongyan Jia.
来源: Minerva Gastroenterol (Torino). 2024年70卷1期137-139页

3532. Serrated polyps <10 mm cannot reliably be characterized by i-Scan without magnification at routine colonoscopy.

作者: Sabrina Gg Testoni.;Chiara Notaristefano.;Giuliano F Bonura.;Maria Napolitano.;Dario Esposito.;Edi Viale.;Lorella Fanti.;Francesco Azzolini.;Giulia M Cavestro.;PierAlberto Testoni.
来源: Minerva Gastroenterol (Torino). 2024年70卷3期306-314页
Colorectal lesions (CRLs) <10 mm found at colonoscopy tend towards "diagnose-and-leave" or "resect-and-discard" strategies based on real-time Kudo glandular pit-pattern's assessment using i-Scan. However, i-Scan has not yet been validated for Kudo's classification. We aimed to assess whether, in routine colonoscopy, i-Scan without magnification and optical enhancement (M-OE) reliably differentiates hyperplastic polyps (HPs) from other serrated lesions (SLs) and conventional adenomas (CAs), and, among SLs, HPs from sessile serrated lesions (SSLs) and traditional or unknown serrated adenomas (TSAs, USAs), in Kudo type II CRLs<10 mm, according to ASGE Preservation and Incorporation of Valuable endoscopic Innovations (PIVI) recommended negative predictive value (NPV) threshold for adenomas.

3533. Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation.

作者: Yandi Xie.;Minghui Li.;Xiaojuan Ou.;Sujun Zheng.;Yinjie Gao.;Xiaoyuan Xu.;Ying Yang.;Anlin Ma.;Jia Li.;Yuemin Nan.;Huanwei Zheng.;Juan Liu.;Lai Wei.;Bo Feng.
来源: BMC Gastroenterol. 2023年23卷1期224页
Since hepatitis B surface antigen (HBsAg) loss is rarely achieved with nucleos(t)ide analog (NA) treatment, most patients require life-long NA treatment. Previous studies have shown that some patients remain virologically responsive even after NA cessation. However, there is still controversy surrounding whether NA discontinuation increases the HBsAg loss rate. Therefore, this study aimed to assess the cumulative rate of HBsAg loss and identify the predictors of HBsAg loss after NA discontinuation.

3534. Efficacy of Crohn's disease exclusion diet in treatment -naïve children and children progressed on biological therapy: a retrospective chart review.

作者: María Clara Jijón Andrade.;Gemma Pujol Muncunill.;Ana Lozano Ruf.;Laura Álvarez Carnero.;Victor Vila Miravet.;Dolores García Arenas.;Natalia Egea Castillo.;Javier Martín de Carpi.
来源: BMC Gastroenterol. 2023年23卷1期225页
Recent trials suggested that the Crohn's disease (CD) exclusion diet (CDED) plus partial enteral nutrition (PEN) is a safe and effective strategy in remission induction of paediatric-onset CD. However, real-world evidence regarding the safety and efficacy of the CDED plus PEN approach is still lacking. The present case-series study reported our experience with the outcomes of CDED plus PEN in the paediatric-onset CD at disease onset and after the loss of response to biologics.

3535. An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients.

作者: Chenchen Zhang.;Liting Zhang.;Weihao Zhang.;Bingxin Guan.;Shuai Li.
来源: BMC Gastroenterol. 2023年23卷1期223页
The Asia-Pacific Colorectal Screening (APCS) score and its derivatives have been used to predict advanced colorectal neoplasia (ACN). However, it remains unknown whether they apply to the current Chinese population in general clinical practice. Therefore, we aimed to update the APCS score system by applying data from two independent asymptomatic populations to predict the risk of ACN in China.

3536. Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.

作者: Yusuke Johira.;Takashi Nakahara.;Takahiro Kinami.;Shintaro Yamasaki.;Masanari Kosaka.;Yuki Shirane.;Ryoichi Miura.;Serami Murakami.;Shigeki Yano.;Kei Amioka.;Kensuke Naruto.;Yuwa Ando.;Yumi Kosaka.;Kenichiro Kodama.;Shinsuke Uchikawa.;Hatsue Fujino.;Atsushi Ono.;Eisuke Murakami.;Wataru Okamoto.;Masami Yamauchi.;Tomokazu Kawaoka.;C Nelson Hayes.;Masataka Tsuge.;Michio Imamura.;Hiroshi Aikata.;Shiro Oka.
来源: BMC Gastroenterol. 2023年23卷1期222页
Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a new classification system for fatty liver disease. In this study, we investigated the clinical characteristics of patients with MAFLD-hepatocellular carcinoma (HCC) in comparison with those with nonalcoholic fatty liver disease (NAFLD) and considered the validity and challenges of the new criteria.

3537. Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.

作者: Sailimai Man.;Yuhan Deng.;Yuan Ma.;Jingzhu Fu.;Heling Bao.;Canqing Yu.;Jun Lv.;Hui Liu.;Bo Wang.;Liming Li.
来源: Gastroenterology. 2023年165卷4期1025-1040页
This study aimed to estimate the prevalence of liver steatosis and fibrosis in the general population and populations with potential risk factors in China, so as to inform policies for the screening and management of fatty liver disease and liver fibrosis in general and high-risk populations.

3538. Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis.

作者: Yunfei Pu.;Xianzhi Meng.;Zhichen Zou.
来源: BMC Gastroenterol. 2023年23卷1期221页
Ulcerative colitis is one of the two main forms of inflammatory bowel disease. Cuproptosis is reported to be a novel mode of cell death.

3539. Timing of endoscopy in patients with cirrhosis and acute variceal bleeding: a single-center retrospective study.

作者: Mengyuan Peng.;Zhaohui Bai.;Deli Zou.;Shixue Xu.;Chunmei Wang.;Metin Başaranoğlu.;Cyriac Abby Philips.;Xiaozhong Guo.;Xiaodong Shao.;Xingshun Qi.
来源: BMC Gastroenterol. 2023年23卷1期219页
The optimal timing of endoscopy in liver cirrhosis with acute variceal bleeding (AVB) remains controversial in current guidelines and studies.

3540. Laboratory risk factors for coexistent primary biliary cholangitis in patients with Sjögren's syndrome: a retrospective study.

作者: Xuan Gao.;Guangzhi Xiao.;Fengfan Yang.;Rongrong Dou.;Miao Xue.;Yingying Zhang.;Zhaohui Zheng.;Jin Ding.
来源: BMC Gastroenterol. 2023年23卷1期220页
Limited research exists on the laboratory characteristics of coexistent primary biliary cholangitis (PBC) and Sjögren's syndrome (SS). This study aimed to investigate the laboratory risk factors for the coexistence of PBC in patients with SS.
共有 4350 条符合本次的查询结果, 用时 4.1240034 秒